LaCAR MDx Technologies
BE-MF-000001212 · Belgium · Liège
LaCAR MDx Technologies is registered in the European database on medical devices as a manufacturer, with 64 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
Most frequent device types declared: E-GQ-576, E-IX-1920, E-IX-480, I-MB-288, I-MD-288.
Devices declared under this manufacturer
- LAMP Human CYP2C9 deficiency KIT
- LAMP Human DPD deficiency KIT - 4 mutations
- LAMP Human FV LEIDEN KIT (rs6025)
- LAMP Human HLA-B27 detection KIT
- LAMP Human Hemochromatosis KIT (rs1800562/rs1799945)
- LAMP Human Hemoglobin S&C mutation KIT (rs334/rs33930165)
- LAMP Human Lactose Intolerance Duplex KIT
- LAMP Human MTHFR 2nd mutation KIT (rs1801131)
- LAMP Human MTHFR mutation KIT (rs1801133)
- NEONATAL 17-OHP Screening ELISA
- NEONATAL MSUD Screening Fluo
- NEONATAL T-GAL Screening Fluo
Showing 12 of 64 declared devices.
Catalogue references include E-GQ-576, E-IX-1920, I-MB-288, I-MD-288, LC-2ndMTHFR-LP-24, LC-HLAB27-LP-96.
European nomenclature codes declared: W01010199, W0106010499, W0106010199, W0103010202, W0102050107, W01020403.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | LACAR MDX TECHNOLOGIES (BE) · FDA 3042250641 |
| Devices in EUDAMED | 64 |
| Country of registration | Belgium |
Device-level evidence
| Devices with a numeric GTIN | 64 |
|---|---|
| Found in the U.S. device database | 1 |
| Share | 1.6 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: United States only. LaCAR MDx Technologies is registered in the United States but was not found in the Canadian register.